This message was sent to ##Email##
|
|
|
|
|
| |
SCAI
SCAI's Emerging Leader Mentorship (ELM) Program is now accepting applications for its 2019-21 cycle. SCAI's ELM Program is tasked with finding a small, select group of up-and-coming physicians and facilitating their transition into the next generation of great thinkers, presenters, teachers and national leaders.
Applications are due by Oct. 15! Submit yours today!
By Rahul Sharma, MD, FSCAI; and Sridevi Pitta, MD, MBA, FSCAI
Acute myocardial infarction (AMI) is the most common cause of cardiogenic shock (CGS), with a mortality rate as high as 50 percent. There has been more than a twofold increase in the incidence of CGS in patients with ST-elevation myocardial infarction (STEMI) from 2003 to 2010, with the increase more marked in women and patients older than 75 years old. Despite recognition of the importance of minimizing time to reperfusion, early revascularization with PCI or CABG was performed in only 51 percent of patients with AMI-CGS in 2010, and mortality rates in these patients have actually increased over time. There has been a paradigm shift in the management of CGS, with the focus on earlier and more widespread use of mechanical circulatory devices (MCS) for LV support, RV support and/or biventricular support. Finally, regional systems of care and a team-based algorithmic approach are being implemented to improve outcomes. This SCAI Tip of the Month is aimed at providing a stepwise approach to the assessment and management of patients presenting with AMI-CGS, incorporating evidence from recently published data.
Pulsara
In the cohort of patients, the utilization of the Pulsara platform decreased the average door-to-balloon times by 22% in patients with acute STEMI arriving at the emergency department. This effect was maintained when looking at the subset of all STEMI cases reportable to CMS. Researchers also observed modest improvements in meeting the less than 60-minute, less than 90-minute benchmarks, and improvements in the resource utilization. Read the full Critical Pathways in Cardiology publication here.
READ MORE
| | CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS |
MDLinx
In elderly acute coronary syndromes patients referred for coronary angiography and prospectively enrolled in the Swiss ACS Cohort between December 2009 and October 2012, researchers examined gender-related differences in outcomes. The estimated one-year major adverse cardiovascular and cerebrovascular events rates were 15 percent and 23 percent in women and men, respectively, in patients over 75 years old. (Catheterization and Cardiovascular Interventions)
READ MORE
|
|
|
|
|
| |
Cath Lab Digest
While it may appear to be a simple issue, the need to know critical lab values and review a chest X-ray before bringing the patient to the cath lab is the standard of care for elective procedures. Does this standard apply to the ST-elevation myocardial infarction (STEMI) patient?
READ MORE
TCTMD
Takotsubo syndrome is associated with morbidity and mortality rates that physicians should not shrug off or dismiss as less than those of acute myocardial infarction, according to authors of a new observational study. They also found substantial rates of hospital readmission — most often for heart failure symptoms — and cardiogenic shock.
READ MORE
Diagnostic and Interventional Cardiology
The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements. The data were presented at the 2018 Transcatheter Cardiovascular Therapeutics annual meeting.
READ MORE
TCTMD
Prior data from the SECURE-PCI study hinted that statin preloading might benefit patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), but a new analysis suggests that the benefit might be particularly pronounced in individuals with ST-segment elevation myocardial infarction (STEMI).
In the overall analysis of STEMI and NSTE ACS patients treated with atorvastatin 80 milligrams prior to PCI, there was a 28 percent reduction in the risk of major adverse events at 30 days when compared with those not preloaded with a statin.
READ MORE
For a complete list of job postings, click here.
To post your resume, click here.
| Date |
Event |
Location |
| Oct. 12-13,
2018 |
SCAI Shock 2018 |
Boston, MA
|
| Nov. 4-5,
2018 |
The VEINS at VIVA 2018 |
Las Vegas, NV
|
| Nov. 5-8, 2018 |
VIVA 18 |
Las Vegas, NV
|
| Dec. 2-4, 2018 |
Innovations in Cardiovascular Interventions Israel Meeting |
ICI, Israel
|
| Dec. 7-11, 2018 |
Fall Fellows 2018 Courses |
Las Vegas, NV
|
| Dec. 8-9, 2018 |
New York City Debates in Interventional Cardiology |
New York, NY
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
